Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)]
- RabMAb
- Recombinant
- What is this?
4
(3 Reviews)
|
(44 Publications)
Rabbit Recombinant Monoclonal ENO1 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse, Rat, Recombinant fragment - Human samples. Cited in 44 publications.
View Alternative Names
ENO1L1, MBPB1, MPB1, ENO1, Alpha-enolase, 2-phospho-D-glycerate hydro-lyase, C-myc promoter-binding protein, Enolase 1, MBP-1, MPB-1, Non-neural enolase, Phosphopyruvate hydratase, Plasminogen-binding protein, NNE, Gamma-enolase, 2-phospho-D-glycerate hydro-lyase, Enolase 2, Neural enolase, Neuron-specific enolase, NSE, ENO2, Beta-enolase, 2-phospho-D-glycerate hydro-lyase, Enolase 3, Muscle-specific enolase, Skeletal muscle enolase, MSE, ENO3
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (AB155102)
Immunocytochemistry/Immunofluorescence analysis of MCF7 cells labelling ENO1 + ENO2 + ENO3 with unpurified ab155102 at a dilution of 1/100.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (AB155102)
Intracellular Flow Cytometry analysis of MCF-7 (human breast carcinoma) cells labeling ENO1 with purified ab155102 at 1/20 dilution (10ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (AB155102)
Immunocytochemistry/Immunofluorescence analysis of MCF-7 cells labelling ENO1 + ENO2 + ENO3 with purified ab155102 at 1/60. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain. ab7291, a mouse anti-tubulin (1/1000) and ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/1000) were also used.
Control 1 : primary antibody (1/60) and secondary antibody, ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/1000).
Control 2 : ab7291 (1/1000) and secondary antibody, ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000).
- IP
Lab
Immunoprecipitation - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (AB155102)
ab155102 (purified) at 1/20 immunoprecipitating ENO1 in HeLa whole cell lysate.
Lane 1 (input) : HeLa whole cell lysate (10μg)
Lane 2 (+) : ab155102 + HeLa whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab155102 in HeLa whole cell lysate.
For western blotting, a HRP-conjugated anti-rabbit IgG, specific to the non-reduced form of IgG was used as the secondary antibody (1/1500).
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Immunoprecipitation - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (ab155102)
Predicted band size: 47 kDa
Observed band size: 47 kDa
false
- WB
Unknown
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (AB155102)
All lanes:
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (ab155102) at 1/1000 dilution
Lane 1:
MCF7 cell lysate at 10 µg
Lane 2:
Jurkat cell lysate at 10 µg
Lane 3:
A431 cell lysate at 10 µg
Lane 4:
HeLa cell lysate at 10 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG at 1/2000 dilution
Predicted band size: 47 kDa
false
- WB
Lab
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (AB155102)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (ab155102) at 1/5000 dilution
Lane 1:
MCF-7 whole cell lysate at 10 µg
Lane 2:
Jurkat whole cell lysate at 10 µg
Lane 3:
HeLa whole cell lysate at 10 µg
Lane 4:
A431 whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 47 kDa
Observed band size: 47 kDa
false
- WB
Lab
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (AB155102)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (ab155102) at 1/5000 dilution
Lane 1:
C2C12 whole cell lysate at 10 µg
Lane 2:
NIH/3T3 whole cell lysate at 10 µg
Lane 3:
Mouse heart tissue lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 47 kDa
Observed band size: 47 kDa
false
- WB
Lab
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (AB155102)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (ab155102) at 1/5000 dilution
All lanes:
Rat brain tissue lysate at 10 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG at 1/1000 dilution
Predicted band size: 47 kDa
Observed band size: 47 kDa
false
- WB
Lab
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (AB155102)
Mouse anti-6x HisTag was used as a loading control.
All lanes:
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] (ab155102) at 1/5000 dilution
Lane 1:
Human ENO3 protein (His Tag) at 0.2 µg
Lane 2:
Human ENO2 Protein (His Tag) at 0.2 µg
Lane 3:
Human ENO1 Protein (His Tag) at 0.2 µg
Predicted band size: 47 kDa
false
Related conjugates and formulations (8)
-
Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)] - BSA and Azide free
-
660 APC
APC Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)]
-
HRP Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)]
-
578 PE
PE Anti-ENO1 + ENO2 + ENO3 antibody [EPR10863(B)]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The ENO1 protein serves multiple functions beyond its glycolytic activity. It also acts as a plasminogen receptor on the cell surface aiding in the modulation of pericellular and extracellular matrix degradation processes. Through this role ENO1 influences cell migration and tissue remodeling. This protein can form part of larger protein complexes contributing to its versatility in various cellular functions.
Pathways
ENO1 plays a critical role in glycolysis a central metabolic pathway that converts glucose into pyruvate generating ATP as a result. In this pathway ENO1 closely interacts with other enzymes like phosphoglycerate kinase and pyruvate kinase. Additionally as a plasminogen receptor ENO1 links to the plasminogen activation pathway affecting fibrinolysis and cellular response to tissue injury.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (44)
Recent publications for all applications. Explore the full list and refine your search
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2403818 PubMed39467260
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational cancer research 13:833-846 PubMed38482406
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:6208 PubMed37798264
2023
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 15:982-994 PubMed36915794
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed36614179
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 42:613-624 PubMed36564470
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell proliferation 56:e13344 PubMed36181462
2022
Applications
Unspecified application
Species
Unspecified reactive species
Aging and disease 13:1488-1503 PubMed36186123
2022
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 8:eabo2295 PubMed35867798
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 82:2666-2680.e11 PubMed35709751
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com